Edition:
United States

Easywell Biomedical Inc (1799.TWO)

1799.TWO on Gre Tai Securities Market of Chinese Taipei

24.30TWD
1:30am EDT
Change (% chg)

NT$-1.20 (-4.71%)
Prev Close
NT$25.50
Open
NT$25.50
Day's High
NT$25.50
Day's Low
NT$24.15
Volume
943
Avg. Vol
411,022
52-wk High
NT$33.21
52-wk Low
NT$20.10

Latest Key Developments (Source: Significant Developments)

Easywell Biomedical says no dividend for 2016
Wednesday, 22 Mar 2017 06:58am EDT 

Easywell Biomedical Inc <1799.TWO>:Says no dividend for 2016.  Full Article

Easywell Biomedical completes issuing T$200 mln 1st series domestic secured convertible corporate bonds
Sunday, 19 Feb 2017 10:54pm EST 

Easywell Biomedical Inc <1799.TWO>:Says it completed issuing T$200 million 1st series domestic secured convertible corporate bonds.  Full Article

Easywell Biomedical says conversion price of 1st series domestic secured convertible corporate bonds is T$21.82 per share
Tuesday, 14 Feb 2017 04:20am EST 

Easywell Biomedical Inc <1799.TWO>:Says the conversion price of the 1st series domestic secured convertible corporate bonds is T$21.82 per share.  Full Article

Easywell Biomedical to liquidate medical equipment unit
Monday, 9 Jan 2017 06:30am EST 

Easywell Biomedical Inc <1799.TWO>:Says it resolved to liquidate its Shenzhen-based medical equipment unit.  Full Article

Easywell Biomedical unit completes pilot SAD pharmacokinetic clinical study of parkinson treatment
Tuesday, 29 Nov 2016 01:25am EST 

Easywell Biomedical Inc <1799.TWO>: Says its 50.2-percent-owned unit completed pilot SAD pharmacokinetic clinical study of parkinson treatment in Malaysia .Says the unit will go on pilot MAD(multiple ascending dose) pharmacokinetic clinical study since December.  Full Article

Easywell Biomedical unit applies clinical trial for TWB-103
Thursday, 6 Oct 2016 11:02pm EDT 

Easywell Biomedical Inc <1799.TWO>:Says its unit applied clinical trial to TFDA for TWB-103 that a fetal skin cells wound dressing.  Full Article

Easywell Biomedical to issue 1st series domestic secured convertible corporate bonds of T$200 mln
Monday, 4 Jul 2016 05:07am EDT 

Easywell Biomedical <1799.TWO>: Says it will issue the 1st series domestic secured convertible corporate bonds, worth T$200 million . Says par value and issue price of T$100,000 for the bonds . Maturity period of three years for the bonds and interest rate is 0 percent .Proceeds to be used to repay bank loan, enrich operating funds, buy laboratory and equipment and invest in long term equity.  Full Article

Easywell Biomedical to issue new shares for T$420 mln
Monday, 4 Jul 2016 03:58am EDT 

Easywell Biomedical <1799.TWO>: Says it will issue 14 million new shares of its common stock with par value of T$10 per share and issue price at T$30 per share .Says the proceeds will be used to repay bank loan, enrich operating funds, buy laboratory and equipment and long term equity investment.  Full Article

Easywell Biomedical announces no dividend payment for 2015
Thursday, 25 Feb 2016 05:05am EST 

Easywell Biomedical Inc:To pay no dividend to shareholders for 2015.  Full Article

Easywell Biomedical to fully acquire Transwell Biotech
Friday, 8 Jan 2016 02:33am EST 

Easywell Biomedical Inc:To fully acquire Transwell Biotech Co., Ltd through stock swap.2.45 shares of Transwell Biotech swap 1 share of Easywell Biomedical.Stock swap record date on June 1.  Full Article

More From Around the Web

No consensus analysis data available.